EN
HI
Vivimed Labs Chart
Vivimed Labs Share Key Metrics
Volume
90549.00
Market Cap
49.09 CR
LTQ@LTP
200@5.92
ATP
5.93
Var Margin
100 %
Circuit Range
5.63-6.21
Delivery %
0 %
Value
5.37 L
ASM/GSM
No
Market Lot
1
Summary
Vivimed Labs share price is ₹5.92 as of 23 Jun, 2026. The stock Vivimed Labs intraday movement has stayed between ₹5.90 and ₹6.11, while on a 52-week basis,Vivimed Labs price 52 week high is ₹29.40 & its 52 week low is ₹5.15.
In terms of trading activity, Vivimed Labs has recorded a volume of 90549 shares, The Vivimed Labs has a market cap of ₹82913915 CR. The stock’s Average Traded Price (ATP) stands at ₹5.93, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 200 @ ₹5.92.
Vivimed Labs operates within a circuit range of ₹5.63 – ₹6.21, with a Value of ₹5.37 L. The Delivery Percentage for the day is 0%. Additionally, Vivimed Labs currently falls under the No framework, and trades with a market lot size of 1.
Vivimed Labs Fundamentals
P/E Ratio
0
P/B Ratio
-0.48
Div. Yield
0
Sector P/E
69.22
Sector P/B
3.07
Sec. Div. Yield
0.53
Vivimed Labs Resistance and Support
Pivot 5.95
Resistance
First Resistance
6.06
Second Resistance
6.21
Third Resistance
6.32
Support
First Support
5.8
Second Support
5.69
Third Support
5.54
Vivimed Labs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-30 | Audited Results |
| 2026-05-28 | Audited Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2025-01-10 | Quarterly Results & Others |
Vivimed Labs News
Vivimed Labs Ltd - 532660 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Vivimed Labs published Form G, inviting expressions of interest for its Corporate Insolvency Resolution Process (CIRP). The deadline for submitting expressions of interest is June 29, 2026, and for resolution plans is August 28, 2026.
Jun 17 2026 13:32:06
Vivimed Labs Ltd - 532660 - Board Meeting Postponed
Vivimed Labs announced the postponement of its Board Meeting, initially scheduled for May 30, 2026, to approve the financial results for the Quarter & Year ended FY 2025-26. The new date for the meeting will be communicated shortly.
May 30 2026 15:17:08
Read More
Vivimed Labs Management
| Name | Position |
|---|---|
| Manohar Rao Varalwar | Chairman |
| Santosh Varalwar | Managing Director |
Vivimed Labs FAQs
The Buying Price of Vivimed Labs share is 5.92 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Vivimed Labs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Vivimed Labs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Vivimed Labs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Vivimed Labs shares is -0.48. Useful to assess the stock's value relative to its book value.
To assess Vivimed Labs’s valuation compare Sector P/E, P/B which are 69.22 & 3.07 with sector averages, along with growth rates and financial metrics.
The Market Cap of Vivimed Labs is 49.09 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Vivimed Labs share price is 29.40 & 5.15. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Vivimed Labs belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
Invest in VIVIMEDLAB
Or Download Choice FinX App
Invest in VIVIMEDLAB
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade